John Snow Labs is a healthcare artificial intelligence (AI) company focusing on AI and natural language processing (NLP) solutions for the healthcare and life sciences sectors. The company provides products including language models for clinical text summarization and question answering, NLP libraries for information extraction and de-identification, and tools for training and deploying AI models. John Snow Labs serves healthcare systems, pharmaceutical companies, and other entities in the healthcare industry. It was founded in 2015 and is based in Lewes, Delaware.

Dyania Health specializes in healthcare artificial intelligence (AI) and focuses on automating the manual review of patient medical histories. Its main offering, Synapsis AI, is a proprietary system that reads electronic medical records (EMRs) in a fraction of a second, enabling faster and more accurate clinical decision-making and patient care. It serves healthcare systems, physicians, and pharmaceutical sponsors by providing tools that support clinical trials and patient treatment processes. It was founded in 2019 and is based in Jersey City, New Jersey.

Massive Bio operates as an artificial intelligence (AI) driven platform specializing in personalized oncology solutions within the healthcare sector. The company offers services connecting cancer patients and oncologists to clinical trials for new, alternative, and targeted treatments, as well as providing personalized treatment recommendations through a virtual tumor board. It primarily serves the healthcare industry, particularly oncology care providers and cancer patients seeking treatment options. It was founded in 2014 and is based in Istanbul, Turkey.

Medaptive Health offers an open source solution for developing and operating consumer-facing health applications. Clients use the platform to develop and push content to participants, collect real world evidence, and analyze the resulting data. Because of our content-driven approach, clients can deploy a solution at a fraction of the time and cost of traditional approaches. The platform supports all devices (Android, iOS, web), as well as sensors and wearables.

ConcertAI specialises in generative and agentic artificial intelligence (AI) solutions within the life sciences and healthcare sectors. The company offers a suite of products that utilise real-world data and AI to support clinical research, facilitate clinical trials, and provide insights for oncology care. ConcertAI's services are directed towards life sciences and healthcare organisations looking to advance translational medicine. ConcertAI was formerly known as Concerto HealthAI. It was founded in 2017 and is based in Cambridge, Massachusetts.

COTA focuses on healthcare, specifically in the domain of cancer care. The company's main services involve the use of proprietary technology, advanced analytics, and deep expertise to organize complex data, providing a comprehensive picture of cancer to advance care and research. COTA primarily serves the healthcare industry, with a specific focus on oncology. It was founded in 2011 and is based in New York, New York.